Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,022 | -2,903 | -4,912 | -4,304 | -6,486 |
| Depreciation Amortization | -44 | -43 | -19 | -10 | 50 |
| Other Working Capital | 528 | 511 | 103 | -203 | -441 |
| Other Operating Activity | 6,551 | -2,712 | 505 | 1,122 | 1,034 |
| Operating Cash Flow | $-6,987 | $-5,147 | $-4,324 | $-3,395 | $-5,843 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,279 | 3,386 | -21 | -3,550 | N/A |
| PPE Investments | -5 | -18 | -27 | N/A | -53 |
| Other Investing Activity | 1,624 | -2,026 | 0 | 0 | 0 |
| Investing Cash Flow | $-660 | $1,342 | $-48 | $-3,550 | $-53 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -28 |
| Common Stock Issued | 12,689 | 10,734 | 931 | 6,720 | 15 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -173 |
| Financing Cash Flow | $12,689 | $10,734 | $931 | $6,720 | $-186 |
| Beginning Cash Position | 7,298 | 369 | 3,810 | 4,034 | 10,117 |
| End Cash Position | 12,340 | 7,298 | 369 | 3,810 | 4,034 |
| Net Cash Flow | $5,042 | $6,929 | $-3,440 | $-225 | $-6,083 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,987 | -5,147 | -4,324 | -3,395 | -5,843 |
| Capital Expenditure | -5 | -18 | -27 | N/A | -53 |
| Free Cash Flow | -6,992 | -5,165 | -4,351 | -3,395 | -5,896 |